Asia Pacific In Vitro Diagnostics Market Size
and Growth Analysis:
The Asia-Pacific In Vitro Diagnostics (IVD) market was
estimated at $15,009 million in 2018 and is expected to reach $ 25,455 million
by 2025, which will be growing at a compound annual growth rate of around 8 %
over the 2018-2025 forecast period.
Browse details of 150
number of pages research report developed on Asia Pacific In Vitro
Diagnostics Market Research Report @ https://www.researchcosmos.com/reports/asia-pacific-cancer-biomarkers-market/1888149688
Asia Pacific In Vitro Diagnostics Market - Drivers,
Challenges and Opportunities:
Obesity, bad eating habits, sedentary lifestyles and high
smoking and alcohol consumption are some of the prominent factors that result
in the high incidence of cancer, diabetes, cardiovascular disease and other illnesses,
which is resulting in the demand for in vitro diagnostics in the Asia Pacific
(APAC). Disability, and increasing population of elderly people susceptible to
illness are also the main engines of market growth. Technological advances in
terms of accuracy, portability and profitability will accelerate demand for IVD
devices.
However, the growth of the market is limited due to the lack
of experienced healthcare professionals and the lack of knowledge of the
population. There is also strong regulation on new products and existing
products and technologies that can limit the growth of the market to a certain
extent. It is expected that the introduction of improved technologies, such as
the miniaturization of microfluidics, biochips and nanobiotechnology, will
increase opportunities for this regional market.
Ask Free Sample of
the Report @ https://www.researchcosmos.com/request/asia-pacific-cancer-biomarkers-market/1888149688
Asia Pacific In Vitro Diagnostics Market Segmentation
Analysis:
Based on this product, the IVD market is classified as
tools, reagents and software. The reagents held a market share of 64.63% due to
the strong use of in-vitro diagnostic tests. Based on technology, market is
divided into areas such as immunology, hematology, clinical chemistry,
molecular diagnosis, coagulation and microbiology. According to the
application, the IVD market is classified as infectious diseases, diabetes,
cancer, cardiology, kidney disease, autoimmune diseases, drug testing and
others.
Geographic Insights
of Asia Pacific In Vitro Diagnostics Market:
The three main markets of the IVD that dominate the
Asia-Pacific region are Japan, India and China. Since 2015, Japan is expected
to lead the IVD market, followed by China and India. With regard to growth, the
Chinese IVD industry is expected to grow rapidly in the coming years. The
growth of this industry in China is due to certain key factors such as rising
health spending, increasing GDP, population growth, increasing coverage and
demand for external consultations.
Key market players profiled in this Asia Pacific In Vitro Diagnostics Market report are
BioMérieux SA, F. Hoffmann-La Roche Ltd. Becton, Dickinson
and Company; Hologic, Inc. (Gen-Probe); Siemens Healthcare; Abbott; Allerdner;
Sysmex Corporation; Qiagen; and Cefeida are some of the significant industry
players.
For any queries,
inquire more @ https://www.researchcosmos.com/inquire/asia-pacific-cancer-biomarkers-market/1888149688
About Us:
Research Cosmos is a provider of standard and customized
Industry research, business intelligence and consulting services across more
than 100 domains in different industries of the world. We host the trending
Industry reports of the world’s top-notch publishing companies, offering
services to a wide range of customers from students to fortune 500 companies
and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
+1 888 709 8757
No comments:
Post a Comment